Half-year report · Q2
3747.TEDINET S100VRG8
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥863m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥940m | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥16m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥62m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥85m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥160m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥27m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥38m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥32m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥40m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥98m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥49m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥17m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥411m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥413m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥819m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥819m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥994m | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥20m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥81m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥106m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥202m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥124m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥24m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥73m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥14m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.53 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.63 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.82 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥162m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥125m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥125m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥21m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥682m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥682m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥224m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥55m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥55m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥24m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥178m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥30,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥30,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥151m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥131m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥131m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥5m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥751m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥751m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥240m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥59m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥59m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥30,000 |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥22m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥940m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥940m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥30,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥213m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 481
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | Prior1YearInstant | 53869000 | JPY |
| Other cl | CurrentQuarterInstant | 51303000 | JPY |
| Current liabilities | Prior1YearInstant | 272264000 | JPY |
| Current liabilities | CurrentQuarterInstant | 287067000 | JPY |
| Long term loans payable | Prior1YearInstant | 126568000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 106552000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 4619000 | JPY |
| Lease obligations ncl | CurrentQuarterInstant | 2913000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 9686000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 14422000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 140873000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 123887000 | JPY |
| Liabilities | Prior1YearInstant | 413137000 | JPY |
| Liabilities | CurrentQuarterInstant | 410954000 | JPY |
| Capital stock | Prior1YearInstant | 1478433000 | JPY |
| Capital stock | CurrentQuarterInstant | 1478433000 | JPY |
| Capital surplus | Prior1YearInstant | 996567000 | JPY |
| Capital surplus | CurrentQuarterInstant | 996567000 | JPY |
| Retained earnings | Prior1YearInstant | -1158703000 | JPY |
| Retained earnings | CurrentQuarterInstant | -1198458000 | JPY |
| Treasury stock | Prior1YearInstant | -95031000 | JPY |
| Treasury stock | CurrentQuarterInstant | -95046000 | JPY |
| Shareholders equity | Prior1YearInstant | 1221266000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 1181496000 | JPY |
| Non controlling interests | Prior1YearInstant | 11566000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 2532000 | JPY |
| Net assets | Prior1YearInstant | 1232832000 | JPY |
| Net assets | CurrentQuarterInstant | 1184028000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 1645970000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 1594983000 | JPY |
| Net sales | Prior1YTDDuration | 940343000 | JPY |
| Net sales | CurrentYTDDuration | 862797000 | JPY |
| Cost of sales | Prior1YTDDuration | 602178000 | JPY |
| Cost of sales | CurrentYTDDuration | 574434000 | JPY |
| Gross profit | Prior1YTDDuration | 338164000 | JPY |
| Gross profit | CurrentYTDDuration | 288362000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 276532000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 272345000 | JPY |
| Operating income | Prior1YTDDuration | 61632000 | JPY |
| Operating income | CurrentYTDDuration | 16017000 | JPY |
| Interest income noi | Prior1YTDDuration | 5000 | JPY |
| Interest income noi | CurrentYTDDuration | 508000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 193000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 307000 | JPY |
| Non operating income | Prior1YTDDuration | 199000 | JPY |
| Non operating income | CurrentYTDDuration | 816000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 744000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 1472000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 87574000 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 100815000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |